SILO PHARMA INC. - COMMON STOCK

1.8400

08-January-25 14:24:50

15 minutes delayed

Stocks

+0.7500

+68.81%

Today's range

1.6600 - 3.3699

ISIN

N/A

Source

NASDAQ

Silo Pharma Awarded US Patent for Groundbreaking PTSD Treatment and Prepares for SPC-15 Clinical Trial

08 Jan 2025 07:29:00 By Nasdaq GlobeNewswire
Silo Pharma Issues Letter to Shareholders Detailing Development Progress and Potential for Lead Assets Targeting PTSD and Chronic Pain

02 Jan 2025 07:45:00 By Nasdaq GlobeNewswire
Silo Pharma Initiates Pharmacokinetic and Tolerability Study for SP-26 Targeting Chronic Pain and Fibromyalgia

18 Dec 2024 06:35:00 By Nasdaq GlobeNewswire
Silo Pharma Enters Joint Development Agreement for SP-26 Ketamine Implant Device Targeting Pain Management

29 Nov 2024 07:05:00 By Nasdaq GlobeNewswire
Silo Pharma Announces Positive Results for Novel SPC-15 Treatment Targeting Stress-Related Disorders

18 Nov 2024 07:40:00 By Nasdaq GlobeNewswire
Silo Pharma Reports Positive Results in Sterilization and Dissolution Testing of SP-26 Ketamine Implant

31 Oct 2024 07:35:00 By Nasdaq GlobeNewswire
Silo Pharma Announces Completion of FDA Pre-IND Meeting to Advance Development of SPC-15 for Treatment of PTSD

10 Sep 2024 05:35:00 By Nasdaq GlobeNewswire
Silo Pharma Expands Development Agreement with Sever Pharma for Novel Ketamine Implant Therapeutic

14 Aug 2024 13:30:00 By Nasdaq GlobeNewswire
Silo Pharma Announces Partnership with Global CRO for Central Nervous System Homing Peptide

07 Aug 2024 07:13:00 By Nasdaq GlobeNewswire
Silo Pharma to Present at H.C. Wainwright Annual Global Investment Conference

26 Jul 2024 07:20:00 By Nasdaq GlobeNewswire
Silo Pharma Announces Closing of $2.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

22 Jul 2024 15:45:00 By Nasdaq GlobeNewswire
Silo Pharma Announces $2.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

19 Jul 2024 07:01:00 By Nasdaq GlobeNewswire
Silo Pharma and Resyca BV Partner on Device and CMC Development for Intranasal PTSD Drug SPC-15

18 Jul 2024 07:25:00 By Nasdaq GlobeNewswire
Silo Pharma Secures Exclusive Global License for Alzheimer's Therapeutic

16 Jul 2024 05:30:00 By Nasdaq GlobeNewswire
IBN (InvestorBrandNetwork) Coverage Initiated for Silo Pharma Inc.

30 Mar 2022 07:30:00 By Nasdaq GlobeNewswire

<<
<
1
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.